Hypothalamic-pituitary mediated modulation of immune function: Prolactin as a neuroimmune peptide

Rheumatology

Volumn 30, Issue 3, 1991, Pages 203-207

  Chikanza, I C ^a   Panayi, G S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXYLIC ACID 2 HYDROXY 1 METHYLPROPYL ESTER; BROMOCRIPTINE; CORTICOSTEROID; CYCLOSPORIN A; DEXAMETHASONE; INTERLEUKIN 1; METOCLOPRAMIDE; MIFEPRISTONE; PERPHENAZINE; PROLACTIN; QUIPAZINE;

ETIOLOGY; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; IMMUNOLOGY; INFLAMMATION; PRIORITY JOURNAL; REVIEW;

ADRENAL CORTEX HORMONES; ANIMAL; CYCLOSPORINS; HUMAN; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNITY; INTERLEUKIN-1; PROLACTIN;

EID: 0025869839     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/30.3.203     Document Type: Review

References (60)

1. Ganong WF. Review of medical physiology. 12th ed. Los Altos: Lange, 1985:352-3.
2. Salas MA, Evans SW, Levell MJ, Whicher JT. Interleukin-6 and ACTH act synergistically to stimulate release of corticosterone from the adrenal gland cells. Clin Exp Immunol 1990;79:470-3.
3. Schauenstein K, Fassler R, Dietrich H, Schwarz S, Kromer G, Wick G. Disturbed immune-endocrine communication in autoimmune disease. Lack of corticosterone response to immune signals in obese strain chickens with spontaneous autoimmune thyroiditis. J Immunol 1987;139:1830-3.
4. Hall JC, Rosbash M. Mutations and molecules influencing biological rhythms. A Rev Neurosci 1988; 373-93.
5. Ritchie AWS, Oswald I, Spedding MH, et al. Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. Br Med J 1983;286:1773-5.
6. Pownall R, Knapp MS. A circadian study of corticosteroid suppression of delayed hypersensitivity. Int J Immunopharmacol 1980;1:293-8.
7. Frantz AG. Prolactin. N Engl J Med 1978;298:201-7.
8. Vekemans M, Robyn C. The influence of exogenous estrogens on the circadian periodicity of circulating prolactin in females. J Clin Endocrinol Meted) 1975;40:886-9.
9. Feder HF. Estrous cyclicity in mammals. In: Adler NT, ed. Neuroendocrinology of reproduction physiology and behaviour. New York: Plenum Press, 1981:279.
10. Negro-Vilar A. Prolactin and growth of the prostate and seminal vesicles. In: Springs Mills E, Hafez ESE, eds. Male accessory glands. New York: Elsevier, 1980:223.
11. Hickle PM. Regulation of prolactin synthesis and secretion by peptide hormones. In: Negro-Vilar A, Lonn PM, eds. Peptide hormones: effects and mechanisms of action. Boca Raton: CRC Press, 1988;3:143.
12. Bern H, Nicoll CS. The comparative endocrinology of prolactin. Rec Prog Horm Res 1968;24:681-720.
13. Lopez FJ, Dominguez JR, Sanihez-Franco F, Negro-Vilar A. Role of dopamine and vasointestinal peptide in the control of the pulsatile prolactin release. Endocrinology 1989;124:527-35.
14. McMichael AJ, McDevitt HO. The association between the HLA system and disease. Prog Med Genet 1977;2:39-95.
15. Human Gene Mapping 10. Tenth International Workshop on Human Gene Mapping. New Haven Conference 1989. Cytogenet Cell Genet 1989;51:154.
16. Whitehouse DJ, Whitehouse MW, Pearson CM. Passive transfer of adjuvant arthritis and allergic encephalitis in rats using thoracic duct lymphocytes. Nature 1969;224:1322.
17. Nagy E, Berci I. Immunodeficiency in hypophysecto-mised rats. Acta Endocrinol 1978;89:530-7.
18. Berci I, Nagy E. Immunodeficiency in hypophysecto-mized rats; restoration by prolactin. (Abstract). Fedn Proc 1981;40:4541.
19. Nagy E, Berci I. Prolactin and contact sensitivity. Allergy 1981;36:429-31.
20. Berci I, Nagy E, Kovacs K, Horwath E. Regulation of humoral immunity in rats by pituitary hormones. Acta Endocrinol 1981;98:506-13.
21. Bemton EW, Meltzer MS, Holaday JW. Suppression of macrophage activation and T lymphocyte function in hypoprolactimaemic mice. Science 1988;239:401-4.
22. McComb DJ, Cairns PD, Kovacs K, Szabo S. Effects of cysteamine on hypothalamic pituitary adrenal axis in rats. Fedn Proc 1985;44:2551-5.
23. Millard WJ, O’Sullivan D, Riskins PN. Effect of cysteamine on suckling-induced prolactin secretion in rats. Life Sci 1987;41:2255-60.
24. Bryant HU, Bemton E, Holaday JW. Cysteamine produces dose-related biphasic immunomodulatory effects in mice. (In press).
25. Gilman A, Goodman LS, Rail TW, Murad F. The pharmacological basis of therapeutics. 7th ed. New York: Macmillan Publishing Company, 1985.
26. Yamauchi J, Takahara J, Ofuji T. Effects of meto-clopramide on rat prolactin secretion in vivo. Life Sci 1977;20:1581-3.
27. Bemton EW, Bryant HU, Holaday JW. Prolactin and immune function. (In press).
28. Spangelo BL, Hall NRS, Ross PC, Goldstein AL. Stimulation of in vivo antibody production and Con-A induced mouse cell spleen cell mitogenesis by prolactin. Immunopharmacology 1987;14: 11-20.
29. Hiestand PC, Mekler P, Nordmann R, Grieder A, Permmongkol C. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action of cyclosporin A. Proc Natl Acad Sci 1986;83:2599-603.
30. Shaskan EG, Lovett EJ. Effects of haloperidol a dopamine receptor antagonist, on delayed cutaneous hypersensitivity reaction to DNCB in mice. Res Commun Psychol Behav 1980;5:241.
31. Sapolsky R, Krey L, McEwen B. The neuroendocrinology of stress and ageing: the glucocorticoid cascade hypothesis. Endocr Rev 1986;3:284-301.
32. Kelley KW, Brief S, Westly HJ, et al. G3 pituitary adenoma can reverse thymic aging in rats. Proc Natl Acad Sci USA 1986;83:5653-7.
33. Bryant H, Bemton E, Holaday J. Morphine-induced immunosuppression: involvement of glucocorticoids and prolactin. Problems of drug dependence. (In press).
34. Bemton EW, Bryant H, Woldeyesus J, Holaday J. Suppression of lymphocyte and adreno-corticol function by corticosterone: in vivo antagonism by prolactin. (Abstract). The Pharmacologist 1988;30: A123.
35. Sternberg EM, Hill JM, Chrousos GP, et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis susceptible Lewis rats. Proc Natl Acad Sci USA 1989;86:2374-8.
36. Bemton EW, Beach JE, Holaday JW, Smallridge RC, Fein HG. Release of multiple hormones by a direct action of IL-1 on pituitary cells. Science 1987;238:519-21.
37. Berkenbosch F, Oers JV, Rey AD, Tilders F, Bese-dovsky H. CRF producing neurons in the rat are activated by IL-1. Science 1987;238:524-6.
38. Sapolsky R, Rivier C, Yamanoti G, Pltsky P, Vale W. IL-1 stimulates the hypothalamic CRF. Science 1987;238:522-4.
39. Eastgate JA, Symons JA, Wood NC, Grinlinton FM. Correlation of IL-1 levels with disease activity in rheumatoid arthritis. Lancet 1988;11:706—9.
40. Sternberg EM, Wider RL, Chrousos GP, et al. The role of the hypothalamic pituitary adrenal axis in susceptibility to arthritis. In: Luderck DK, Chrousos G, Tolis G, eds. Proceedings of the Third International Symposium on Challenges of Hypersecretion: Cushing’s syndrome and other hypercortisolemic states. New York: Raven Press, 1989.
41. Harkness JAL, Ritcher MP, Panayi GS, et al. Circadian variation in disease activity in rheumatoid arthritis. Br Med J 1982;284:551-3.
42. Saldanha C, Touzas G, Grace E. Evidence for the anti-inflammatory effects of normal circulating plasma cortisol. Clin Exp Rheumatol 1986;4:365-6.
43. Chikanza IC, Pownall R, Panayi GS. Immunoendo-crine interactions in the pathogenesis of rheumatoid arthritis: initiating and perpetuating factors? Br J Rheumatol 1990;29(Suppl 2):22.
44. Fraga A, Jara LJ, Graef A, Lavalle C. Prolactin and gonadal hormones in SLE patients. (Abstract) Arthritis Rheum 1988;A74:S24.
45. Carrier M, Emery RW, Moblay W, Perrotta NJ, Russell DH, Copeland J. Prolactin as a marker of rejection in human heart transplantation. Transplant Proc 1987;3442-3.
46. Carrier M, Russell DH, Wild JC. Prolactin as a marker of rejection in human heart transplantation. J Heart Transplant 1987;6:290-2.
47. Cosson C, Myara I, Guillemain R, Amrein C, Dreyfus G, Moatti N. Serum prolactin as a rejection marker in heart transplantation. Clin Chem 1989;35:492-3.
48. Hiestand PC, Mekler P. Mechanism of action. Cyclosporin A and prolactin-mediated control of immunity. Proc Allergy 1986;38:239-46.
49. Hartman DP, Holaday JW, Bemton EW. Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J 1989;3:2194-2202.
50. Gillis S, Crabtree G, Smith K. Glucocorticoid inhibition of T-cell growth factor production II. The effect on the in vitro generation of cytolytic T cells. J Immunol 1979;123:1632-8.
51. McIntyre OR, Eurenius K, Holland FC, Ebaugh FG. Studies on the mechanism of inhibition of the PHA response. In: Riede WO, ed. Proceedings of the Third Leucocyte Culture Conference. New York: Appleton-Century-Crofts, 1969.
52. Tormey DC, Fudenberg HH, Kamin R. Effect of prednisolone on the synthesis of DNA and RNA by human lymphoctyes in vitro. Nature 1967;213:281-2.
53. Russell DH, Larson DF. Prolactin-induced polyamine biosynthesis in spleen and thymus; specific inhibition by cyclosporin. Immunopharmacology 1985;9:165-74.
54. Bellussi G, Muccioli G, Ghe C, DiCarlo R. Prolactin binding sites in human erythrocytes and lymphocytes. Life Sci 1987;41:951-9.
55. Buckley AR, Crowe PD, Pulnam CW, Russell DH. Rapid activation of rat liver protein kinase by prolactin in vitro and by partial hepatectomy. FASEB J 1989;3:abstr 27.
56. Morris DR, Allen ML, Rabinovitch PS, Kuepfer CA, White MW. Mitogenic signalling pathways regulating expression of c-myc and ornithine decarboxylase genes in bovine T lymphocytes. Biochemistry 1988;27:8689-92.
57. Clevenger C, Russell DH, Shipman P, Prystowsky M. IL-2 driven T cells secrete and require a prolactinlike lymphokine for proliferation. FASEB J 1989;3:abstr 523.
58. Whyte A, Williams RO. Bromocriptine suppresses post-partum exacerbation of collagen-induced arthritis. Arthritis Rheum 1988;31:927-8.
59. Palestine AG, Coulombre CGM, Kim MK, Gelato M, Nussenblatt RB. Bromocriptine and low dose cyclosporin in the treatment of experimental autoimmune uveitis in the rat. J Clin Invest 1987;79:1078-81.
60. Dougados M, Duchesne L, Amor B. Bromocriptine and cyclosporin combination therapy for rheumatoid arthritis. Arthritis Rheum 1988;31:1333.